Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Travis Hunt

Orthopaedic Surgery Georgetown, KY Medical Doctor

NPI 1780635672 CMS profile 307954

101 Windsor Path, Georgetown, KY 40324

Open in the dashboard

General payments

$85,025

221 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Travis Hunt of Georgetown, KY is reported in the CMS Open Payments database as having received $85,025 across 221 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,374 16
2024 General $12,133 29
2023 General $45,155 87
2022 General $7,866 16
2021 General $976 23
2020 General $1,017 13
2019 General $9,504 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Travis Hunt
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Travis Hunt were reported at $8,374. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Travis Hunt Orthopaedic Surgery median Middle half National median
2019 $9,504 $644 $140–$2,844 $163
2020 $1,017 $312 $75–$1,860 $114
2021 $976 $520 $117–$2,495 $132
2022 $7,866 $598 $128–$2,731 $149
2023 $45,155 $461 $128–$2,264 $160
2024 $12,133 $497 $134–$2,475 $164
2025 $8,374 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $79,949 115 payments
  2. DePuy Synthes Sales Inc. $3,092 66 payments
  3. Nevro Corp. $533 5 payments
  4. Abbott Laboratories $428 6 payments
  5. Smith+Nephew, Inc. $273 1 payment
  6. Ethicon US, LLC $197 12 payments
  7. SI-BONE, Inc. $149 1 payment
  8. Globus Medical, Inc. $127 2 payments
  9. Sanara MedTech Inc. $86 1 payment
  10. Horizon Therapeutics plc $41 3 payments
  11. Other $150 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $61,138 12 payments
  2. Travel and Lodging $15,623 44 payments
  3. Food and Beverage $7,778 163 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $273 1 payment
  5. Education $212 1 payment
Products named General payments · program years 2019–2025
  1. CONFIDENCE SPINAL CEMENT SYSTEM $57,833 30 payments
  2. SYNAPSE Spine $57,700 29 payments
  3. SYMPHONY Spine $57,700 29 payments
  4. MOUNTAINEER Spine $57,700 29 payments
  5. SYMPHONY Spine $6,801 8 payments
  6. MOUNTAINEER Spine $6,749 4 payments
  7. SYNAPSE Spine $6,749 4 payments
  8. CONFIDENCE $3,940 2 payments
  9. CONDUIT $3,066 23 payments
  10. Teligen $2,984 27 payments
  11. Other $12,474 126 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

467

Median for Orthopedic Surgery: 203

Drug cost

$2,746

Median for Orthopedic Surgery: $1,433

Branded share of claims

44.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 124 $1,000
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 85 $575
Oxycodone Hcl Generic 48 $234
Gabapentin Generic 45 $231
Diclofenac Sodium Generic 12 $191
Methocarbamol Generic 27 $165
Tizanidine Hcl Generic 13 $110
Meloxicam Generic 62 $87
Tramadol Hcl Generic 24 $75
Ibuprofen Generic 13 $66

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 89 billing codes

Paid by Medicare

$161,717

Of which drugs: $221

Medicare patients

271

Average age 72

Services billed

825

156 women, 115 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 31%
Depression 30%
Ischemic heart disease 28%
COPD 21%
Chronic kidney disease 20%
Osteoporosis 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 25 41 $220

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

221 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record